Search

Search Results
Results 11 - 20 of 375 for Gene therapy technologies
  • Cytiva
    Supplier Profile
    Cytiva, we are a global provider of technologies and services that advance and accelerate the development, manufacture, and delivery of therapeutics. Our rich heritage dates back...
  • Nanogen Biopharmaceutical
    Supplier Profile
    NANOGEN BIOPHARMACEUTICAL is a leading company that is doing research and development of active Biopharmaceutical ingredients (APIs), and specific therapeutic injections in Asia Pacific region, based...
  • Strem Chemicals
    Supplier Profile
    Strem Chemicals, Inc. established in 1964, is a privately–held company that manufactures and markets specialty chemicals of high purity. Its clients include academic, industrial and government...
  • Georgia Institute of Technology
    Supplier Profile
    The Georgia Institute of Technology is one of the nation's top research universities, distinguished by its commitment to improving the human condition through advanced science and...
  • Cheap Tubes Inc.
    Supplier Profile
    Located in Vermont, Cheap Tubes is a leading supplier of Carbon Nanotubes & Graphene products.  We will soon enter the Silver Nanowire and ITO alternative ink markets. Every order we receive...
  • Nanomedicine Driving Innovations Within The Healthcare Sector
    Article - 4 Aug 2006
    CPI has identified six key drivers influencing the transformation of the healthcare sector, which will create many opportunities for innovation.
  • S-Evans Biosciences Opens New Technology Facility in China
    News - 24 Aug 2010
    Cryo-Cell International, Inc. (OTCBB:CCEL) ("the Company"), one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences (SEB), the...
  • Benitec Launches New Exploratory Cellular Therapy Program in Collaboration with ReNeuron
    News - 23 Jun 2015
    Benitec Biopharma is pleased to announce the launch of a new exploratory cellular therapy program including exosome-based delivery utilising the Company's proprietary ddRNAi technology. Entry into...
  • Preclinical Data Demonstrates Potent Anti-Viral Activity of TKM-Marburg Therapeutic Treatment
    News - 26 Sep 2013
    Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced today that preclinical data demonstrating potent anti-viral activity of TKM-Marburg were...
  • Quantum Materials Corp and Nanoaxis Form Technology Alliance to Mass Produce Tetrapod Quantum Dots
    News - 20 Sep 2011
    Quantum Materials Corporation and Nanoaxis, LLC announce the formation of a technology alliance combining Quantum Materials tetrapod quantum dot mass production technology with Nanoaxis advanced...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback